Dermatology
Latest News
Oral IL-23 receptor antagonist for psoriasis promising: Phase 2b study
Similar to the primary outcome of PASI 75, all treatment groups demonstrated a statistically significant dose-response in PASI 90, compared with...
Latest News
JAK inhibitors efficacious for atopic dermatitis in Asian patients, study finds
The Singapore study is one of the few that have examined the safety and efficacy of JAK inhibitors for treatment of AD in a non-White population...
Latest News
Study finds subcutaneous spesolimab reduces flares in patients with GPP
The intravenous formulation of spesolimab was approved for the treatment of GPP flares in adults by the Food and Drug Administration in September...
Photo Rounds
Focal plaques and finger swelling
Latest News
FDA adds safety-related information to its dermal filler webpage
The update relates delayed-onset inflammation that has been reported to occur near filler treatment sites after viral or bacterial illnesses or...
Photo Rounds
Nails falling off in a 3-year-old
Latest News
New guidelines for MTX use in pediatric inflammatory skin disease unveiled
One of the recommendations states that liver biopsy is not indicated for routine monitoring of pediatric patients taking low-dose MTX.
Latest News
Hairy moles may contain the cure for baldness: Study
Researchers analyzed hair follicle stem cells and discovered that a molecule called osteopontin drives accelerated hair growth.
Latest News
For psoriasis, review finds several biosimilars as safe and effective as biologics
“The biosimilars evaluated in this study could be considered alongside originators for biologic-naive patients to improve the accessibility of...
Feature
Does colchicine have a role in treating excess ASCVD risk in patients with chronic inflammatory conditions?
Experts in rheumatology, dermatology, and gastroenterology assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic...
Latest News
Study points to need to improve identification of culprit in SJS/TEN cases
A single culprit drug was labeled in 17 cases, but physicians communicated certainty in only 7 of those cases.